Home

Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX)

5.4500
+0.0800 (1.49%)
NASDAQ · Last Trade: Jun 11th, 2:06 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Why Recursion Pharmaceuticals Was Bouncing Higher on Tuesdayfool.com
Via The Motley Fool · June 10, 2025
Recursion Pharmaceuticals Stock Is Up 10% Today: What's Happening?benzinga.com
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading higher and trending. The company on Tuesday announced a reduction in personnel and infrastructure aimed at extending its cash runway.
Via Benzinga · June 10, 2025
Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
Via Benzinga · June 10, 2025
Recursion Pharmaceuticals Stock Surges After Company Lays Off 20% Workforce: Retail Predicts ‘Blue Skies’ Aheadstocktwits.com
The company now expects its projected cash runway to extend into the fourth quarter of 2027.
Via Stocktwits · June 10, 2025
Earnings Scheduled For May 5, 2025benzinga.com
Via Benzinga · May 5, 2025
Applied Digital And Riot Platforms Are Among Top 10 Mid-Cap Gainers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio?benzinga.com
Via Benzinga · June 8, 2025
Recursion Pharmaceuticals Stock Surges On Breakthrough AI Model Launch With MITbenzinga.com
Shares of Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict molecular binding affinity with unmatched speed and accuracy.
Via Benzinga · June 6, 2025
3 Monster Stocks to Hold for the Next 10 Yearsfool.com
A handful of industries are on the verge of explosive growth. These three companies are poised to gain the most.
Via The Motley Fool · May 26, 2025
8 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · May 23, 2025
These Are the Only 6 Stock Stocks in NVIDIA's 13F Portfolio
While institutional money managers have released their Q1 holdings, so has the heart and soul of the AI revolution, NVIDIA. See which six stocks NVIDIA owns.
Via MarketBeat · May 22, 2025
Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip?fool.com
Via The Motley Fool · May 12, 2025
2 Top Artificial Intelligence (AI) Stocks to Buy Right Nowfool.com
Via The Motley Fool · May 11, 2025
Why Recursion Pharmaceuticals Stock Plummeted 24% This Weekfool.com
Via The Motley Fool · May 9, 2025
Why Recursion Pharmaceuticals Stock Is Plummeting Todayfool.com
Via The Motley Fool · May 6, 2025
Why Recursion Pharmaceuticals Stock Was Getting Mashed on Mondayfool.com
Via The Motley Fool · May 5, 2025
Retail Traders Bearish On Recursion Pharma Ahead of Q1 Results Despite Positive Tupelo Trial Datastocktwits.com
Traders flagged a key technical level at $4.65 and raised concerns over an outlier patient in the Tupelo trial, with attention now turning to management’s commentary during the earnings call.
Via Stocktwits · May 4, 2025
How Do Investors Really Feel About Recursion Pharmaceuticals?benzinga.com
Via Benzinga · May 1, 2025
3 Monster Stocks to Hold for the Next 10 Yearsfool.com
They're not just leaders of their industry. Their underlying businesses are also on the verge of enormous growth.
Via The Motley Fool · April 23, 2025
This Beaten-Down Artificial Intelligence (AI) Stock Just Got Some Great News: Time to Buy?fool.com
Via The Motley Fool · April 18, 2025
Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market Newsstocktwits.com
Via Stocktwits · April 15, 2025
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testingbenzinga.com
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.
Via Benzinga · April 14, 2025
Top 3 Biotech Stocks That Got Retail Street Buzzing Last Week: SMMT, PTN, RXRXstocktwits.com
Positive expectations from key clinical trials, delisting fears and some regulatory changes triggered a flurry of discussions on Stocktwits for these tickers for the week ended April 11, 2025.
Via Stocktwits · April 13, 2025
These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio?benzinga.com
Top mid-cap stock performers last week: AGL, RXRX, CERT, AVAV, STRL, ORLA, IAG, SBSW, LOAR, RYTM, TLX. High gains due to positive news and macro uncertainty.
Via Benzinga · April 13, 2025
The market is filled with gapping stocks in Friday's session.chartmill.com
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via Chartmill · April 11, 2025
Why Recursion Pharmaceuticals Stock Is Skyrocketing Todayfool.com
Via The Motley Fool · April 11, 2025